192 related articles for article (PubMed ID: 30139425)
1. A Case for Alpha-Lipoic Acid as an Alternative Treatment for Diabetic Polyneuropathy.
Nguyen N; Takemoto JK
J Pharm Pharm Sci; 2018; 21(1s):177s-191s. PubMed ID: 30139425
[TBL] [Abstract][Full Text] [Related]
2. [α-Lipoic acid as the main pharmacological drug for in- and outpatient treatment of diabetic polyneuropathy].
Strokov IA; Phokina AS
Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(3):50-55. PubMed ID: 28399096
[TBL] [Abstract][Full Text] [Related]
3. Treatment of symptomatic diabetic peripheral neuropathy with the anti-oxidant alpha-lipoic acid. A 3-week multicentre randomized controlled trial (ALADIN Study).
Ziegler D; Hanefeld M; Ruhnau KJ; Meissner HP; Lobisch M; Schütte K; Gries FA
Diabetologia; 1995 Dec; 38(12):1425-33. PubMed ID: 8786016
[TBL] [Abstract][Full Text] [Related]
4. Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a 7-month multicenter randomized controlled trial (ALADIN III Study). ALADIN III Study Group. Alpha-Lipoic Acid in Diabetic Neuropathy.
Ziegler D; Hanefeld M; Ruhnau KJ; Hasche H; Lobisch M; Schütte K; Kerum G; Malessa R
Diabetes Care; 1999 Aug; 22(8):1296-301. PubMed ID: 10480774
[TBL] [Abstract][Full Text] [Related]
5. [Alpha-lipoic acid in the treatment of diabetic polyneuropathy].
Chukanova EI; Chukanova AS
Zh Nevrol Psikhiatr Im S S Korsakova; 2018; 118(1):103-109. PubMed ID: 29460914
[TBL] [Abstract][Full Text] [Related]
6. Thioctic acid for patients with symptomatic diabetic polyneuropathy: a critical review.
Ziegler D
Treat Endocrinol; 2004; 3(3):173-89. PubMed ID: 16026113
[TBL] [Abstract][Full Text] [Related]
7. The clinical efficacy of epalrestat combined with α-lipoic acid in diabetic peripheral neuropathy: Protocol for a systematic review and meta-analysis.
Wang X; Lin H; Xu S; Jin Y; Zhang R
Medicine (Baltimore); 2018 Feb; 97(6):e9828. PubMed ID: 29419686
[TBL] [Abstract][Full Text] [Related]
8. Clinical experience with thioctacid (thioctic acid) in the treatment of distal symmetric polyneuropathy in Korean diabetic patients.
Hahm JR; Kim BJ; Kim KW
J Diabetes Complications; 2004; 18(2):79-85. PubMed ID: 15120701
[TBL] [Abstract][Full Text] [Related]
9. The sensory symptoms of diabetic polyneuropathy are improved with alpha-lipoic acid: the SYDNEY trial.
Ametov AS; Barinov A; Dyck PJ; Hermann R; Kozlova N; Litchy WJ; Low PA; Nehrdich D; Novosadova M; O'Brien PC; Reljanovic M; Samigullin R; Schuette K; Strokov I; Tritschler HJ; Wessel K; Yakhno N; Ziegler D;
Diabetes Care; 2003 Mar; 26(3):770-6. PubMed ID: 12610036
[TBL] [Abstract][Full Text] [Related]
10. Alpha-lipoic acid in the treatment of diabetic polyneuropathy in Germany: current evidence from clinical trials.
Ziegler D; Reljanovic M; Mehnert H; Gries FA
Exp Clin Endocrinol Diabetes; 1999; 107(7):421-30. PubMed ID: 10595592
[TBL] [Abstract][Full Text] [Related]
11. A systematic review and meta-analysis of α-lipoic acid in the treatment of diabetic peripheral neuropathy.
Han T; Bai J; Liu W; Hu Y
Eur J Endocrinol; 2012 Oct; 167(4):465-71. PubMed ID: 22837391
[TBL] [Abstract][Full Text] [Related]
12. Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a meta-analysis.
Ziegler D; Nowak H; Kempler P; Vargha P; Low PA
Diabet Med; 2004 Feb; 21(2):114-21. PubMed ID: 14984445
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the analgesic effect of ɑ-lipoic acid in treating pain disorders: A systematic review and meta-analysis of randomized controlled trials.
Cassanego G; Rodrigues P; De Freitas Bauermann L; Trevisan G
Pharmacol Res; 2022 Mar; 177():106075. PubMed ID: 35026405
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of alpha-lipoic acid supplementation in the treatment of symptomatic diabetic neuropathy.
Foster TS
Diabetes Educ; 2007; 33(1):111-7. PubMed ID: 17272797
[TBL] [Abstract][Full Text] [Related]
15. Alpha lipoic acid combined with epalrestat: a therapeutic option for patients with diabetic peripheral neuropathy.
Wang X; Lin H; Xu S; Jin Y; Zhang R
Drug Des Devel Ther; 2018; 12():2827-2840. PubMed ID: 30233145
[TBL] [Abstract][Full Text] [Related]
16. Differential efficacy of methylcobalamin and alpha-lipoic acid treatment on symptoms of diabetic peripheral neuropathy.
Han Y; Wang M; Shen J; Zhang Z; Zhao M; Huang J; Chen Y; Chen Z; Hu Y; Wang Y
Minerva Endocrinol; 2018 Mar; 43(1):11-18. PubMed ID: 27901334
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of α-lipoic acid in diabetic neuropathy.
Papanas N; Ziegler D
Expert Opin Pharmacother; 2014 Dec; 15(18):2721-31. PubMed ID: 25381809
[TBL] [Abstract][Full Text] [Related]
18. Ranking Alpha Lipoic Acid and Gamma Linolenic Acid in Terms of Efficacy and Safety in the Management of Adults With Diabetic Peripheral Neuropathy: A Systematic Review and Network Meta-analysis.
Prado MB; Adiao KJB
Can J Diabetes; 2024 Jun; 48(4):233-243.e10. PubMed ID: 38295879
[TBL] [Abstract][Full Text] [Related]
19. Effects of Oral Alpha-Lipoic Acid Treatment on Diabetic Polyneuropathy: A Meta-Analysis and Systematic Review.
Hsieh RY; Huang IC; Chen C; Sung JY
Nutrients; 2023 Aug; 15(16):. PubMed ID: 37630823
[TBL] [Abstract][Full Text] [Related]
20. Alpha lipoic acid: a new treatment for neuropathic pain in patients with diabetes?
Mijnhout GS; Alkhalaf A; Kleefstra N; Bilo HJ
Neth J Med; 2010 Apr; 68(4):158-62. PubMed ID: 20421656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]